DealImmunoBiota Therapeutics, a Melbourne-based diabetes-focused microbiome biotech, is raising $5 million in a Seed round; investors were not disclosed.
More on Startup Daily →
SEED
08/29/2026
Sonera, Inc., a Berkeley, CA-based neural signal sensor company, was...
Norbert Health, a Brooklyn, NY-based autonomous robotic nursing platform,...
Medulance, a New Delhi-based tech-enabled ambulance network, raised ₹24...
Moonwalk Biosciences, a South San Francisco, CA-based RNAi therapies for...
Thyme Care, a Nashville-based oncology care navigation platform, raised...
Scan.com, an Atlanta-based diagnostic imaging booking platform, raised $90...
Stay informed on industry shifts, deal trends, and career opportunities in venture capital.
